Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">DepoMed target lowered to $19 at RBC Capital Mkts — Starboard agreement reached bringing CEO/Board changes; 1Q outlook below Street (14.23)RBC Capital Mkts lowers their DEPO tgt to $19 from $22. DEPO announced Tuesday after-market a «cooperation agreement» with Starboard that included the replacement of its CEO/President as well as a new Chairman of the Board and three new directors. It also pre-announced a miss on Q1 revenue, with 2017 guidance expected to be «revised» on its Q1 earnings call (week of 5/8); Sector Perform.</td> </tr></table>"